After a proof-of-concept clinical trial failed to meet its main goal, Immunovant announced that it will not pursue further development of its experimental therapy IMVT-1402 (imeroprubart) as a treatment for cutaneous lupus erythematosus (CLE). Immunovant sponsored a Phase 2 study (NCT06980805) that compared IMVT-1402 with a placebo…
Discussion
There is a space that too many people with lupus are forced to live in, between being considered “disabled” and being expected to function as though nothing were wrong. I know that space. Many of you also know it or are caring for a family member who lives in…
Discussion
Something empowering happens when you wake up with a special song looping in your mind. You know, the line or two of lyrics that gently wakes you, continues in your subconscious, then seeps into your fully awake brain until the song is looping in the background of your day. It…
Lupus is an autoimmune inflammatory disease that can affect multiple systems in the body.
While the cause of lupus is often unknown, it is possibly due to a combination of genetics and the environment.
Lupus affects people in different ways, and symptoms vary among patients. Symptoms come and go during periods called flares.
